CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 113 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $932,114 | +64.5% | 62,516 | +20.8% | 0.01% | +75.0% |
| Q2 2023 | $566,608 | -87.8% | 51,745 | -90.3% | 0.00% | -85.7% |
| Q1 2023 | $4,633,642 | +1285.8% | 531,381 | +896.4% | 0.03% | +1300.0% |
| Q4 2022 | $334,373 | -42.5% | 53,329 | -67.9% | 0.00% | -33.3% |
| Q3 2022 | $582,000 | +285.4% | 166,245 | +223.8% | 0.00% | +200.0% |
| Q2 2022 | $151,000 | +43.8% | 51,334 | +52.4% | 0.00% | 0.0% |
| Q1 2022 | $105,000 | +26.5% | 33,680 | +37.5% | 0.00% | 0.0% |
| Q4 2021 | $83,000 | +22.1% | 24,491 | +30.9% | 0.00% | 0.0% |
| Q3 2021 | $68,000 | -75.5% | 18,713 | -70.6% | 0.00% | -66.7% |
| Q2 2021 | $278,000 | -59.6% | 63,700 | -57.9% | 0.00% | -66.7% |
| Q1 2021 | $688,000 | +54.6% | 151,440 | +95.2% | 0.01% | +50.0% |
| Q4 2020 | $445,000 | +8.0% | 77,579 | +36.2% | 0.01% | 0.0% |
| Q3 2020 | $412,000 | +649.1% | 56,966 | +259.7% | 0.01% | +500.0% |
| Q2 2020 | $55,000 | +175.0% | 15,836 | +19.4% | 0.00% | 0.0% |
| Q1 2020 | $20,000 | -51.2% | 13,259 | -36.9% | 0.00% | 0.0% |
| Q4 2019 | $41,000 | -77.2% | 21,021 | -40.1% | 0.00% | -75.0% |
| Q3 2019 | $180,000 | +19.2% | 35,096 | +66.4% | 0.00% | +33.3% |
| Q2 2019 | $151,000 | -28.8% | 21,095 | -21.6% | 0.00% | -70.0% |
| Q4 2018 | $212,000 | +182.7% | 26,897 | +295.7% | 0.01% | +150.0% |
| Q3 2018 | $75,000 | -37.0% | 6,798 | -23.6% | 0.00% | -33.3% |
| Q2 2018 | $119,000 | -61.5% | 8,903 | -62.5% | 0.01% | -66.7% |
| Q1 2018 | $309,000 | – | 23,769 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |